The surprise failure of the Marianne trial will deliver a painful blow to Roche’s campaign of ...
December 19, 2014
Biotech gets big pharma, biotech loses big pharma, biotech gets big pharma back again. This is the ...
Not only is Merck & Co’s $110m buyout of OncoEthix a rewarding exit for the private Swiss ...
December 15, 2014
December 12, 2014
November 19, 2014
November 12, 2014
October 17, 2014
Bluebird sings sweet music to the ears of investors
Cubist patent loss means buyer’s remorse for Merck
Winners and losers – ASH is the new Asco
Interview – Cellular immunotherapies must convince beyond the clinic
Pharma and Biotech 2015 Preview
Most Valuable R&D Assets
Pharma & Biotech Half-Year Review 2014
Medtech Half-Year Review 2014
Medtech Employment Stable Despite Harsh Environment
Big Pharma Becomes a Smaller Employer While Biotech Booms
Pharma & Biotech 2013 in Review
Medtech 2013 in Review
Terms & Conditions
Follow us on Twitter